@admin / longevity-researchmission

Longevity Research

Succeeded
Elapsed
391.4s
Cost
Free
Tokens
0
0 in · 0 out
Events
28
click to inspect
live output
Starting mission longevity-research…
==> Longevity-research mission tick starting
==> Swarm tick starting. KB: {'entities': 127, 'relations': 0}
==> Goal: Anchor the first human-validated causal relation in the mTORC1–autophagy–inflammaging axis by re-gating to the IL-6/hs-C
── Phase 1: Director
Focus: FOCUS AREAS:
── Phase 2: Scouts
1. Colocalized cis-pQTL MR of *RPTOR*/*TSC2* against the IL-6/hs-CRP dyad: Fine-map high-confidence plasma protein-quantitative-trait loci for *RPTOR* and *TSC2* and perform colocalizati
[clinicaltrials] fetched 0 items
[opentargets] error: HTTP Error 400: Bad Request
[opentargets] fetched 0 items
[europepmc] fetched 60 items
[medrxiv] fetched 30 items
[biorxiv] fetched 30 items
[pubmed] fetched 0 items
[pubmed] esearch error: <urlopen error [Errno -3] Temporary failure in name resolution>
Items: 120
── Phase 3: Synthesizer
── Phase 4: Critic
── Phase 5: Curator
Findings: 0, Hypotheses: 5
── Phase 6: Reporter
── Phase 7: Director-meta
==> Tick complete. Findings: 0, Hypotheses: 5
==> Tick complete.
Outputs
{
  "result": " The most significant development this tick was not a positive experimental result, but the instantiation of a rigorous, three-pillar causal inference framework targeting the mTORC1–autophagy–inflammation axis. Because the knowledge graph currently holds 127 entities and zero causal relations, the swarm’s immediate priority is to anchor one high-confidence directed edge linking nutrient sensing to inflammaging. The chosen intervention node is mTORC1 perturbation—examined through cis-protein quantitative trait loci for the core regulators *RPTOR* and *TSC2* and through pharmacologic and genetic inhibition in primary human macrophages. The downstream readouts are circulating IL-6 and high-sensitivity CRP, with autophagy-lysosomal mediators (*ATG7*, *LAMP2*, *SQSTM1*) positioned as formal causal intermediates. No new empirical findings were generated this cycle; tangible progress consisted of five refined hypotheses and the analytical specifications needed to rule out linkage confounding and pleiotropy.\n\nThe biological model under examination is a cellular recycling and inflammation rheostat. mTORC1 serves as a master nutrient sensor: when amino acids and growth signals are abundant, it keeps the transcription factors TFEB and TFE3 locked in the cytoplasm, thereby suppressing autophagy—the lysosomal degradation pathway that clears damaged proteins and organelles. Inhibit mTORC1, whether with rapamycin or through genetic knockdown of its scaffold *RPTOR*, and TFEB/TFE3 translocate into the nucleus, switching on autophagic and lysosomal gene programs. In parallel, mTORC1 inhibition typically attenuates NF-κB signaling, reducing phosphorylation of the p65 subunit and lowering secretion of IL-6, a key driver of chronic age-related inflammation. The unresolved question is whether this sequence forms a true causal cascade in humans, and which specific autophagy node transmits the signal.\n\nEvidence supporting this exact causal chain remains fragmented and low-to-moderate in confidence. Rapamycin extends lifespan and suppresses inflammation in mice (animal evidence), and mTOR inhibitors induce autophagy markers in cultured human cells (in vitro evidence). Genome-wide association studies further report correlations between mTOR-pathway genetic variation and inflammatory biomarkers (human observational/genetic correlation). However, none of these layers alone demonstrates that variation in *RPTOR* or *TSC2* causally alters human IL-6 *through* autophagy rather than through independent pleiotropic pathways. This tick’s design directly addresses that inferential gap, but because the colocalization, macrophage assays, and multivariable mediation analyses are pending, the mediated effect remains hypothetical.\n\nThe next tick will focus on executing these prespecified analyses to populate the knowledge graph’s first causal triplet. Outstanding questions include whether cis-pQTLs for *RPTOR* and *TSC2* genuinely share causal variants with IL-6 or hs-CRP GWAS signals (requiring colocalization posterior probability >0.8); whether primary human macrophages exhibit a dose-dependent reduction in NF-κB p65 Ser536 phosphorylation and secreted IL-6 under mTORC1 inhibition; and which autophagy-lysosomal mediator—if any—carries the largest indirect effect in formal multivariable Mendelian randomization. Should the genetic signals fail to colocalize or the macrophage dose-response prove non-linear, the swarm will need to revise the causal architecture before expanding to broader cytokine panels.\n\nOverall confidence in the general direction of the mTORC1–autophagy–inflammation axis is high, grounded in decades of model-organism and cell-biology research. Confidence that this specific human causal path will survive strict genetic triangulation, however, is necessarily cautious and awaits empirical data. The commitment to rigorous, hype-free reporting means acknowledging this tick’s null empirical output as essential foundational work. These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 5
}
Inference calls7